Anti-Candida albicans effectiveness of citral and investigation of mode of action

References

• Adorjan B, Buchbauer G. (2010). Biological properties of essential oils: An updated review. Flavour Frag J, 25, 407–426.
   Web of Science ®Google Scholar
• Bakkali F, Averbeck S, Averbeck D, Idaomar M. (2008). Biological effects of essential oils–a review. Food Chem Toxicol, 46, 446–475.
   PubMed Web of Science ®Google Scholar
• Baran M, Borowski E, Mazerski J. (2009). Molecular modeling of amphotericin B-ergosterol primary complex in water II. Biophys Chem, 141, 162–168.
   PubMed Web of Science ®Google Scholar
• Cohen BE. (1998). Amphotericin B toxicity and lethality: A tale of two channels. Int J Pharmacol, 162, 95–106
   Google Scholar
• Costa EV, Teixeira SD, Marques FA, Duarte MC, Delarmelina C, Pinheiro ML, Trigo JR, Sales Maia BH. (2008). Chemical composition and antimicrobial activity of the essential oils of the Amazon Guatteriopsis species. Phytochemistry, 69, 1895–1899.
   PubMed Web of Science ®Google Scholar
• Dellau S, Cateaus E, Berges T, Berjeaud J-M, Imbert C. (2008). In vitro activity of terpenes against Candida biofilms. Inter J Antim Agents, 31, 572–576.
   PubMedGoogle Scholar
• Eggimann P, Garbino J, Pittet D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis, 3, 685–702.
   PubMed Web of Science ®Google Scholar
• Eloff JN. (1998). A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med, 64, 711–713.
   PubMed Web of Science ®Google Scholar
• Enoch DA, Ludlam HA, Brown NM. (2006). Invasive fungal infections: A review of epidemiology and management options. J Med Microbiol, 55, 809–818.
   PubMed Web of Science ®Google Scholar
• Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA. (1999). In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. Diagn Microbiol Infect Dis, 33, 75–80.
   PubMed Web of Science ®Google Scholar
• Escalante A, Gattuso M, Pérez P, Zacchino S. (2008). Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J Nat Prod, 71, 1720–1725.
   PubMed Web of Science ®Google Scholar
• Ferreira MSC, Fonteles MC. (1989). Aspectos etnobotânicos e farmacológicos do Cymbopogon citratus Stapf (capim limão). Rev Bras Farm, 70, 94–97.
   Google Scholar
• Ferreira TM, Silva FS, Teodoro GR, Costa ACBP, Maria A, Beltrame Júnior M, Khouri S. (2009). Citral antifungal activity against Candida genus yeasts isolated from hospitalized patients. Rev Inst Adolfo Lutz, 68, 118–125.
   Google Scholar
• Frost DJ, Brandt KD, Cugier D, Goldman R. (1995). A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiot, 48, 306–310.
   PubMed Web of Science ®Google Scholar
• Garcia R, Alves ESS, Santos MP, Viegas A, Fernandes AAR, Santos RB, Ventura JA, Fernandes PMB. (2008). Antimicrobial activity and potential use of monoterpenes as tropical fruits preservatives. Braz J Microbiol, v. 39, 163–168.
   Google Scholar
• Gomes CL, Cavalcante JE, Cunha FA, Amorim LN, Menezes EA. (2010). Identificação e perfil de sensibilidade de Candida spp. isoladas de urina de pacientes com candidúria em Iguatu-Ceará. Rev Bras Anal Clin, 42, 223–225.
   Google Scholar
• Kett DH, Azoulay E, Echeverria PM, Vincent JL. (2011). Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in an intensive care unit study. Crit Care Med, 39, 1–6.
   Google Scholar
• Klepser ME, Wolfe EJ, Pfaller MA. (1998). Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. J Antimicrob Chemother, 41, 397–401.
   PubMed Web of Science ®Google Scholar
• Kriengkauykiat J, Ito JI, Dadwal SS. (2011). Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol, 3, 175–191.
   PubMedGoogle Scholar
• Lampen JO, Arnow PM, Safferman RS. (1960). Mechanism of protection by sterols against polyene antibiotics. J Bacteriol, 80, 200–206.
   PubMed Web of Science ®Google Scholar
• Lima IO, Oliveira RAG, Lima EO, Souza EL, Farias NP, Navarro DF. (2005). Inhibitory effect of some phytochemicals in the growth of yeasts potentially causing opportunistic infections. Braz J Pharm Sci, 41, 199–203.
   Google Scholar
• Lunde CS, Kubo I. (2000). Effect of polygodial on the mitochondrial ATPase of Saccharomyces cerevisiae. Antimicrob Agents Chemother, 44, 1943–1953.
   PubMed Web of Science ®Google Scholar
• Menezes EA, Mendes LG, Cunha FA. (2009). Resistência a antifúngicos de Candida tropicalis isoladas no Estado do Ceará. Rev Soc Bras Med Trop, 2, 354–355.
   Google Scholar
• NCCLS (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Second Edition. NCCLS document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards.
   Google Scholar
• NCCLS (2008). Performance standards of antimicrobial susceptibility testing: Ninth informational supplement. NCCLS document M100-S9. Wayne, PA: National Committee for Clinical Laboratory Standards, pp 120–126.
   Google Scholar
• Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. (2010). Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis, 51, 561–570.
   PubMed Web of Science ®Google Scholar
• Paquet MJ, Fournier I, Barwicz J, Tancrède P, Auger M. (2002). The effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers as viewed by 2H NMR. Chem Phys Lipids, 119, 1–11.
   PubMed Web of Science ®Google Scholar
• Park MJ, Gwak KS, Yang I, Kim KW, Jeung EB, Chang JW, Choi IG. (2009). Effect of citral, eugenol, nerolidol and alpha-terpineol on the ultrastructural changes of Trichophyton mentagrophytes. Fitoterapia, 80, 290–296.
   PubMed Web of Science ®Google Scholar
• Rates SM. (2001). Plants as source of drugs. Toxicon, 39, 603–613.
   PubMed Web of Science ®Google Scholar
• Richardson M, Lass-Flörl C. (2008). Changing epidemiology of systemic fungal infections. Clin Microbiol Infect, 14 Suppl 4, 5–24.
   PubMedGoogle Scholar
• Saddiq AA, Khayyat SA. (2010). Chemical and antimicrobial studies of monoterpene: Citral. Pesticide Bioch Phys, 98, 89–93.
   Web of Science ®Google Scholar
• Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J. (2003). Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother, 47, 2404–2412.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Odds FC. (2002). Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences. Lancet Infect Dis, 2, 73–85.
   PubMed Web of Science ®Google Scholar
• Silva Cde B, Guterres SS, Weisheimer V, Schapoval EE. (2008). Antifungal activity of the lemongrass oil and citral against Candida spp. Braz J Infect Dis, 12, 63–66.
   PubMed Web of Science ®Google Scholar
• Svetaz L, Agüero MB, Alvarez S, Luna L, Feresin G, Derita M, Tapia A, Zacchino S. (2007). Antifungal activity of Zuccagnia punctata Cav.: evidence for the mechanism of action. Planta Med, 73, 1074–1080.
   PubMed Web of Science ®Google Scholar
• Vasconcelos-Júnior AA, Menezes EA, Cunha FA. (2011). Chromogenic medium for direct susceptibility testing of Candida spp. isolated from urine. Mycopathologia, 171, 1–6.
   PubMedGoogle Scholar